Cite
HARVARD Citation
Flanagan, E. et al. (2020). Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Alimentary pharmacology & therapeutics. 52 (10), pp. 1551-1562. [Online].